Improved methods of diagnosis have indicated that chordoma more frequently affects the central nervous system than was previously suspected. For example, in a large neurosurgical service, one can now expect to see one or two cases a year. The world literature in 1960, derived mostly from isolated case reports, mentioned 548 cases of chordoma in the following locations: 240 intracranial, 81 vertebral, and 227 sacrococcygeal (Forti and Venturini, 1960) . Few large series, however, have been published from single institutions (Dahlin and MacCarty, 1952; Poppen and King, 1952; Congdon. 1952) . This paper presents all histologically confirmed cases of chordoma, 30 in number, seen at the Columbia Presbyterian Medical Centre since 1927.
MATERIAL
The 30 cases of chordoma discussed in this report have all been histologically verified by biopsy and five have in addition been confirmed by necropsy. Sixteen of these cases were diagnosed on clinical grounds since 1950. After diagnosis, all these patients were treated by surgery and/or radiotherapy. DISTRIBUTION Chordomas are classified according to their origin from intracranial, vertebral, or sacrococcygeal sites. A separation of the intracranial group into those arising from the clivus and those arising elsewhere in the cranium, however, is not useful clinically because of the marked overlapping of symptoms.
Early reviews noted a preponderance of sacrococcygeal chordomas; more recent studies have shown chordomas to be equally divided between intracranial and sacrococcygeal locations (Faust, Gilmore, and Mudgett, 1944; Forti and Venturini, 1960; Zoltan and Fenyes, 1960) . The vertebral group accounts for only 15 % of all these tumours, their distribution being cervical, lumbar, and thoracic in 157 decreasing order of frequency. The median age of onset of symptoms is the middle thirties for intracranial chordoma and middle fifties for other chordomas. Males outnumber females 3 : 1 (Dahlin and MacCarty, 1952) . Our cases differ from other series in distribution, 16 being intracranial, nine vertebral (four cervical, one thoracic, four lumbar), and five sacrococcygeal. The age of onset varied from the post-pubertal years to the eighth decade (Table 1 ). The age distribution INTRACRANIAL Symptoms were usually present for one year before the patient was admitted to hospital for study (Table II) . The most frequent symptoms of onset were headache of a generalized nature and/or a visual disturbance. The most common visual complaint was diplopia although decreased visual acuity or ptosis have also been reported (Table III) . Eleven patients had been closely followed for longer than one year. In seven symptoms had progressed within this period following therapy. The average time until evidence of recurrence was II months. In our total series of intracranial chordoma, the average time of survival at this time was 43 months (3-6 years) following surgical and/or radiation therapy, or 56 months (4-7 years) from the onset of symptoms. In contrast, in untreated intracranial chordoma, the average survival time from onset of symptons was 28-8 months (Mabrey, 1935) . Of the 16 patients in this series, six were able to return to normal activities in school or work after initial treatment, although at this time no patient is thought to be free of tumour.
CERVICAL All four patients noted pain as their initial symptom. In three the pain was localized to the posterior neck, and in the fourth, the initial pain was in the mastoid region. Further progress of the disease resulted in increasing pain spreading to the arms and shoulders in two patients and the appearance of a mass in the other two patients. The masses were retropharyngeal in one patient and 'pre-auricular' in the other. Generally, symptoms were present for one year before admission to hospital was advised.
On (Rosenqvist and Saltzman, 1959) . Other symptoms which these authors reported included decreased sensation and strength in the lower extremities, while examination usually revealed long tract signs with pathological reflexes and motor and sensory impairment below the lesion. Laboratory studies were reported as normal except for elevation of the cerebrospinal fluid protein which, in our patient, was 594 mg. % associated with a complete cerebrospinal fluid block. This is again consistent with reports in the literature, as partial or complete block was usually found by the time the patient was first admitted to hospital. Radiography in our patient revealed increased density of the involved vertebra, without collapse, and definition of a soft tissue mass. Vertebral collapse and osteolytic lesions are, however, as frequently present as are the findings just described (Windeyer, 1959) .
Since this tumour cannot be completely removed, the time of recurrence will depend mainly on the major direction of growth of the tumour. In our case, the patient was well and at work for two years following decompressive laminectomy and radiation therapy (Table II) . He was then lost to follow-up. In general, the lesion will be fatal within six years of the onset of symptoms (Baker and Coley, 1953 Radiography revealed pedicle erosion and widening of intervertebral foramina in two patients, collapse of a vertebral body in one, and increased bone density with some radiolucent areas in the last. Similar changes have been previously described in the literature (Allen, 1955; Sennett, 1953; Windeyer, 1959) .
Recurrence of tumour was noticed in all patients within one year of combined operative and radiation therapy. Though one patient has been symptom free for seven years following a second course of radiotherapy, it is doubtful if any is free of tumour. Survival has been reported to be less than six years from the onset of symptoms (Baker and Coley, 1953) . To this time, average survival has been seven years from the onset of symptoms and four years from the time of initial diagnosis and therapy in this group of patients. of whom one died 4-5 years after the onset of symptoms and only one is back at work (Table I1) noted in all patients before admission to hospital were perirectal, buttock, or thigh pain, or disturbed sensation and sphincter disturbance, usually constipation and/or incontinence. On examination, all patients had a retro-rectal mass which lay beneath the rectal mucosa but did not penetrate it. In addition, two patients had saddle anaesthesia. Laboratory studies were always reported within normal limits.
Radiography revealed destructive or radiolucent areas in the sacrum and coccyx (Fig. 4) . No osteoblastic areas were noted nor was widening of the spinal canal observed (Hsieh and Hsieh, 1936) . Barium enema examination showed the rectum and sigmoid colon to be displaced anteriorly.
The tumour recurred after therapy within one year in four of five cases. The average survival time from onset of symptoms has been five years; survival from time of therapy has been three years (Table II) . Survival from the time of onset of symptoms has been reported to be one to six years but survival for longer periods has not been unusual (Faust et a!., 1944) . Only one patient has returned to work following therapy of such tumours at this site.
DIAGNOSIS
The diagnosis of chordoma can rarely be made on clinical grounds alone. By combining the clinical picture with radiographic findings, however. a diagnosis of chordoma may be strongly suspected.
The intracranial chordomata can be divided clinically into two groups: those in a parasellar location affecting cranial nerves 1 through 7 and those chordomas of the clivus which involve the eighth through twelfth cranial nerves and often the upper cervical spinal cord. Cases of the former group generally present with a triad of headache, visual disturbances, and diplopia (Givner, 1945; Meaney, Greenwald and Phalen. 1956; Moya, 1960) . Givner (1945) states: 'Unexplained paralysis of the lateral rectus muscle ... in a patient in his thirties with progression to chiasmal signs, headaches preceding defects of the visual fields and no evidence of disorder of the pituitary should suggest chordoma'.
Symptoms of impotence, loss of libido, or disordered menstruation were present in 10 to 20% of cases. Papilloedema and optic atrophy are seen with equal frequency, being present in 20 % of cases (Givner, 1945) . No patient in our series presented with papilloedema although four had optic atrophy.
On radiographic examination, erosion of the clinoid processes, destruction of the sphenoid wing, and enlargement of the sella turcica were most often seen with destruction of some part of the sella in 70 % of cases (Utne and Pugh, 1955) . Suprasellar calcification is present in from 30 to 75 % of cases (Halper, 1949; Moya, 1960; Wood and Himadi, 1950) . If sphenoid sinus involvement was present, biopsy of the sinus usually led to a positive diagnosis (Dahlin and MacCarty, 1952) .
Of the special radiographic studies, gas encephalography generally proved more helpful than arteriography since these tumours arise from the midline. Gas encephalography will demonstrate posterior and superior displacement of the aqueduct and third ventricle with non-filling of the anterior portion of the third ventricle (Utne and Pugh, 1955; Wood and Himadi, 1950) . This was found in all of our gas encephalograms and in 90% of those reported by Moya (1960) . In addition, ventricular dilatation was present in 20% of the patients studied.
In (Sennett, 1953) .
The thoracic chordoma is unlikely to give any specific signs clinically or radiologically of its identity. Symptoms of spinal cord compression, such as pain, lower extremity weakness, and sphincter disturbance, are seen. Radiological examination shows an osteolytic lesion with an adjacent soft tissue mass. If no soft tissue mass is present, the radiological appearance of the vertebra may mimic an angiomatous process. The major differential diagnoses are metastatic tumour, haemangioma, myeloma, chondroma, and giant cell tumour (Sennett, 1953) .
Lumbar chordomas demonstrate clinical and radiographic findings identical with those of the thoracic group (Baker and Coley, 1953; Morris and Rabinovitch, 1947; Sennett, 1953) . Though neither the lumbar nor thoracic areas are common sites for chordoma, the former site is involved twice as frequently as the latter.
Sacrococcygeal chordoma will present with pain or a mass, usually both being present. If a sacral mass presents posteriorly, however, no pain will be felt. Disturbance of sphincter control, most often constipation, is also common. In our series, all patients presented with pain, sphincter disturbance, and a palpable retro-rectal mass. Twenty-nine of 32 patients presented with pain and 50% with either a mass or sphincter disturbance in the series of Dahlin and MacCarty (1952) . Other symptoms of weakness, paraesthesias, and numbness were less constant, being present in less than 20 % of patients.
On examination, the most constant finding is a mass (Dahlin and MacCarty, 1952; Gentil and Coley, 1948) . When the mass presents anteriorly, it may displace the rectum or bladder, although invasion of the mucosa of these organs has not yet been reported. Other findings are related to the degree of nerve root involvement found. This tumour has been reported in patients as young as 2 years (Montgomery and Wolman, 1933) . In Mabrey's (1935) collected series of 85 sacrococcygeal chordomas, four patients were below the age of 9 years.
The distinctive radiological findings of sacrococcygeal chordoma have been described by Hsieh and Hsieh (1936) . These are expansion of the sacrum in which it appears widened in one or more diameters; rarefaction or destruction of bone; trabeculation; and calcifications. Erosion of bone was found on radiographs in 80% of our cases. Previous studies have noted osteolytic lesions in at least 75 % of patients (Utne and Pugh, 1955) .
The differential diagnosis of this tumour includes all of the presacral tumours (Castro, 1961 There has not been a case reported of total removal of an intracranial chordoma. Embryological studies of the notochord in the base of the skull have demonstrated that the notochord traverses bony structures to lie both on the dorsum sellae intracranially and against the basilar portion of the occipital bone extracranially (Gardner and Turner, 1941; Sensenig, 1956) . Neoplastic change of the notochord thus gives rise to a midline tumour which may grow up into the base of the brain or down into the sphenoid sinus or into the nasopharynx. The tumour is unencapsulated or has a pseudo-capsule and invades both dura and bone with facility.
When seen at operation, the tumour has usually grown more to one side than another causing predominately unilateral symptoms. Rather than presenting as a single large mass, several lobules of tumour connected by small bridges of tumour tissue are seen. The basilar cisterns are collapsed by the upward growth of the tumour and the third ventricle, pons, and aqueduct are pushed upward and backward. Thus, hydrocephalus is most often due to a combination of aqueductal compression and collapsing of the basilar absorbing surfaces making external decompression the only means of achieving reduction of increased intracranial pressure.
Since the intracranial portion of the chordoma starts at the dorsum sellae, it may follow a pathway of growth predominately into the middle and anterior fossae or into the posterior fossa. Anterior growth will cause dysfunction of the hypophysis and upper cranial nerves by direct tumour growth to and around these structures. Posterior growth will mainly affect the lower cranial nerves.
It has previously been noted that most patients with intracranial chordoma have a sixth nerve palsy (Givner, 1945) . The reason for this is evident when one considers that the sixth nerve must course over the greatest bulk of the tumour to reach its foramen of exit.
At necropsy, the tumour is seen to grow as a sheet of cells over the floor of the middle or posterior fossa with many large lobules arising from this sheet. The tumour is noted to surround completely nerve and vascular structures rather than push them aside. Thus, anteriorly, the intracranial carotid artery is buried within the tumour while the cavernous sinus, being a more rigid structure, is invaded by tumour. When removal of the tumour is attempted, parts of it are found to be soft and to yield to suction easily; other parts are highly vascular or solid and are not amenable to this form of removal.
The chordoma often has a massive retropharyngeal component and when first seen appears to be a tumour only of the nasopharynx. The tumour, however, when traced posteriorly will be seen to arise from the base of the skull or the cervical vertebrae. At the time of necropsy, an intracranial or intraspinal extension of the tumour is always noted. Thus, total removal of these nasopharyngeal chordomas is impossible.
In the vertebral region, the chordoma surrounds the spinal cord, resembling a metastatic tumour, and causes compression within the bony canal. The tumour's growth, however, may be as extensive anteriorly into the retropleural or retroperitoneal space as it is posteriorly. Our series included several cases in which the surgeon believed that total removal of the tumour had been accomplished only to find recurrence within one year. This is understandable in the light of the gross pathology. Since whatever notochordal remnants the chordoma arises from are present within the body of the vertebra or disc, rather than external to them, it is evident that simple removal of tumour from around the spinal dura cannot effect total removal.
At necropsy, the chordoma can be seen infiltrating Attempts at discrete removal of extradural tumour alone must be unsuccessful because of the constant infiltration of the tumour into the sacrum.
A punched-out area composed solely of fragmented bone and tumour will usually be found within the sacrum. Thus, because its location allows radical excision, sacrococcygeal chordoma is the only type that may be removed totally.
Another facet of chordoma growth is the presence of metastases. Though metastases occur not infrequently from sacrococcygeal chordoma, there are isolated reports of metastases from other parts of the neuraxis (Faust et al., 1944; Gentil and Coley, 1948; Graf, 1944; Greenwald, Meaney, and Hughes, 1957; Guthert and Henkel, 1941; Mabrey, 1935; Maynard, 1953; Morris and Rabinovitch, 1947; Schneegans and Mandigas, 1938; Toole and loannovich, 1960; Uhr and Churg, 1949) . Spread from the sacrococcygeal region has been reported to the peritoneum, lymph nodes, liver, lung, and pleura. Of the seven reported cases of metastases from chordoma outside of the sacrococcygeal region, two have been from intracranial chordoma, both spreading to the lung but one to the heart as well, one from the cervical region to the lung, one from the thoracic region to the lung, and three from the lumbar region. Spread from the lumbar region has been to the lung and in one case to the brain and pancreas as well.
Three patients in our series demonstrated metastases, one each from intracranial, cervical, and sacrococcygeal locations. In the first two cases, metastases were to the lung only whereas the sacrococcygeal tumour spread to the liver, lymph nodes, skin, and lung. It is of interest that the patients with intracranial and cervical chordomas survived 15 and nine years respectively and both received radiotherapy in excess of 10,OOOr tumour dose. The patient with a sacrococcygeal chordoma received 6,100r tumour dose and survived for seven yeais. That the two factors of long survival and massive radiation may have enhanced tumour spread must be considered.
MANAGEMENT
With the realization that total removal of a chordoma cannot be performed except occassionally in the sacrococcygeal region, therapy must be directed toward surgical decompression of vital structures followed by radiation (Dahlin and MacCarty, 1952; Hass, 1934; Rosenqvist and Saltzman, 1959; Sennett, 1953) . Radiotherapy is administered as palliation and can result in regression of tumour and relief of pain.
An evaluation of different methods of therapy in the largest series of patients treated at one institution concludes that a combination of surgery and radiotherapy offers the best chance of prolonging survival (Dahlin and MacCarty, 1952 O'Sullivan, 1961) . In a follow-up period of as long as 12 years, but averaging six years, 12 patients are still alive, seven without recurrence. In addition to operation, 13 patients received post-operative radiotherapy. No report has been made on postoperative morbidity but of the first eight patients reported, only one was noted to have returned to work (MacCarty, Waugh, Mayo, and Coventry, 1952) .
In our patients, the dose of radiation has been steadily increased over the years so that a 3,000 to 5,OOOr tumour dose will be given as the initial treatment dose and doses of 2,000 to 3,000r tumour dose repeated as often as recurrence is noted (Table It) 
